検索条件

閉じる

検索結果 1329 件

フルテキストURL fulltext.pdf
著者 Takaya, Yoichi| Nakayama, Rie| Yokohama, Fumi| Toh, Norihisa| Nakagawa, Koji| Miyamoto, Masakazu| Ito, Hiroshi|
発行日 2022-11-30
出版物タイトル Plos One
巻 17巻
号 11号
出版者 Public Library Science
開始ページ e0278172
ISSN 1932-6203
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 Takaya et al.
論文のバージョン publisher
PubMed ID 36449497
DOI 10.1371/journal.pone.0278172
Web of Science KeyUT 000905496400001
関連URL isVersionOf https://doi.org/10.1371/journal.pone.0278172
フルテキストURL fulltext20230207-1.pdf
著者 Matsumoto, Jun| Nishimoto, Anzu| Watari, Shogo| Ueki, Hideo| Shiromizu, Shoya| Iwata, Naohiro| Takeda, Tatsuaki| Ushio, Soichiro| Kajizono, Makoto| Fujiyoshi, Masachika| Koyama, Toshihiro| Araki, Motoo| Wada, Koichiro| Zamami, Yoshito| Nasu, Yasutomo| Ariyoshi, Noritaka|
キーワード Genetic variant Polymorphism Renal cell carcinoma Survival UDP-glucuronosyltransferase
備考 This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s11010-022-04637-4|
発行日 2022-12-26
出版物タイトル Molecular and Cellular Biochemistry
巻 478巻
号 8号
出版者 Springer Science and Business Media LLC
開始ページ 1779
終了ページ 1790
ISSN 0300-8177
NCID AA00745800
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
論文のバージョン author
PubMed ID 36571650
DOI 10.1007/s11010-022-04637-4
Web of Science KeyUT 000904010400001
関連URL isVersionOf https://doi.org/10.1007/s11010-022-04637-4
フルテキストURL fulltext.pdf
著者 Akhtar, Muhammad Shahbaz| Aslam, Sohaib| Ditta, Allah| Albalawi, Bedur Faleh A.| Oki, Yoko| Nakashima, Yoshitaka|
キーワード Azolla biomass bioconcentration factor Cu removal efficiency Cu toxicity translocation factor
発行日 2022-12-28
出版物タイトル Sustainability
巻 15巻
号 1号
出版者 MDPI
開始ページ 497
ISSN 2071-1050
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
DOI 10.3390/su15010497
Web of Science KeyUT 000909376900001
関連URL isVersionOf https://doi.org/10.3390/su15010497
フルテキストURL fulltext.pdf
著者 Osinde, Cyprian| Sakamoto, Wataru| Kajiya-Kanegae, Hiromi| Sobhy, Islam S.| Tugume, Arthur K.| Nsubuga, Anthony M.| Galis, Ivan|
キーワード Quantitative trait locus (QTL) stem borer herbivory BTx623 and NOG recombinant inbred lines (RILs) sorghum
発行日 2023-12-31
出版物タイトル Journal Of Plant Interactions
巻 18巻
号 1号
出版者 Taylor & Francis Ltd
開始ページ 2153182
ISSN 1742-9145
NCID AA11980303
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 The Author(s).
論文のバージョン publisher
DOI 10.1080/17429145.2022.2153182
Web of Science KeyUT 000905581600001
関連URL isVersionOf https://doi.org/10.1080/17429145.2022.2153182
フルテキストURL fulltext.pdf
著者 Eguchi, Takanori| Csizmadia, Eva| Kawai, Hotaka| Sheta, Mona| Yoshida, Kunihiro| Prince, Thomas L.| Wegiel, Barbara| Calderwood, Stuart K.|
キーワード epithelial-to-mesenchymal transition (EMT) hybrid E/M partial EMT SCAND1 MZF1 SCAN zinc finger transcription factors gene expression cancer prognosis collective migration metastasis
発行日 2022-12-10
出版物タイトル Cells
巻 11巻
号 24号
出版者 MDPI
開始ページ 3993
ISSN 2073-4409
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36552758
DOI 10.3390/cells11243993
Web of Science KeyUT 000900505200001
関連URL isVersionOf https://doi.org/10.3390/cells11243993
フルテキストURL fulltext20221207-2.pdf
著者 Kunii, Yuki| Tanabe, Yoshinori| Nakamoto, Akira| Nishioka, Kunio|
キーワード Volumetric modulated arc therapy (VMAT) Patient-specific quality assurance (QA) 2D detector Gamma passing rate
備考 © 2022 American Association of Medical Dosimetrists. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.meddos.2022.06.003] . | This full-text will be available in Oct. 2023.|
発行日 2022-10-31
出版物タイトル Medical Dosimetry
巻 47巻
号 4号
出版者 Elsevier BV
開始ページ 329
終了ページ 333
ISSN 0958-3947
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 American Association of Medical Dosimetrists.
論文のバージョン author
PubMed ID 35850758
DOI 10.1016/j.meddos.2022.06.003
Web of Science KeyUT 000886274900005
関連URL isVersionOf https://doi.org/10.1016/j.meddos.2022.06.003
JaLCDOI 10.18926/AMO/64127
フルテキストURL 76_6_749.pdf
著者 Takami, Masanari| Yukawa, Yasutsugu| Noda, Yusuke| Yoshida, Munehito| Yamada, Hiroshi|
抄録 We provide the first report of successful salvage surgery for a post-C1 laminectomy symptomatic recurrence of a retro-odontoid pseudotumor (ROP) that caused myelopathy. The 72-year-old Japanese woman presented with an ROP causing symptomatic cervical myelopathy. With ultrasonography support, we performed the enucleation of the ROP via a transdural approach and fusion surgery for the recurrence of the mass. At the final observation 2-year post-surgery, MRI demonstrated the mass’s regression and spinal cord decompression, and the patient’s symptoms had improved. Our strategy is an effective option for a symptomatic recurrence of ROP.
キーワード recurrent retro-odontoid pseudotumor salvage surgery transdural resection C1 laminectomy ultra-sonography
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 749
終了ページ 754
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549779
Web of Science KeyUT 000905195100017
JaLCDOI 10.18926/AMO/64121
フルテキストURL 76_6_705.pdf
著者 Higashikawa, Toshihiro| Ito, Tomohiko| Mizuno, Takurou| Ishigami, Keiichiro| Kuroki, Kengo| Maekawa, Naoto| Usuda, Daisuke| Izumida, Toshihide| Yamada, Shinya| Sangen, Ryusho| Hamada, Kazu| Kiyosawa, Jun| Saito, Atsushi| Iguchi, Masaharu| Kasamaki, Yuji| Nakahashi, Takeshi| Fukuda, Akihiro| Saito, Hitoshi| Kanda, Tsugiyasu| Okuro, Masashi|
抄録 The sodium glucose transporter 2 (SGLT2) inhibitor tofogliflozin is a glucose-lowering drug that causes the excretion of surplus glucose by inhibiting SGLT2. Because of tofogliflozin’s osmotic diuresis mechanism, patients’ serum electrolytes, body fluid levels, and cardiac function must be monitored. We retrospectively analyzed the cases of 64 elderly Japanese patients with type 2 diabetes mellitus (T2DM) who received tofogliflozin for 3 months. Their HbA1c, serum electrolytes (sodium, potassium, chloride), hematocrit, brain natriuretic peptide (cardiac volume load marker) and renin and aldosterone (RAA; an index of regulatory hormones involved in body fluid retention) were continuously monitored during the investigation period. Renal function and cardiac function (by echocardiography) were assessed throughout the period. HbA1c significantly decreased (β1=−0.341, p<0.0001, linear regression analysis [LRA]). Most of the hormonal, electrolyte, and physiological parameters were maintained throughout the study period. In these circumstances, E/e’ tended to decrease (β1=−0.382, p=0.13, LRA). Compared to the baseline, E/e’ was significantly decreased at 1 and 3 months (p<0.01, p<0.05). In the higher E/e’ group (E/e’≥10, n=34), E/e’ decreased significantly (β1=−0.63, p<0.05, LRA). ΔE/e’ was correlated with body-weight change during treatment (r=0.64, p<0.01). The 3-month tofogliflozin treatment improved glycemic control and diastolic function represented by E/e’ in T2DM patients, without affecting serum electrolytes, renal function, or RAA. No negative impacts on the patients were observed. Three-month tofogliflozin treatment lowered glucose and improved cardiac diastolic function.
キーワード tofogliflozin SGLT2 inhibitor elderly patient HbA1c cardiac diastolic function
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 705
終了ページ 713
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549773
Web of Science KeyUT 000905195100011
JaLCDOI 10.18926/AMO/64116
フルテキストURL 76_6_661.pdf
著者 Abe, Yuko| Taira, Naruto| Kashiwabara, Kosuke| Tsurutani, Junji| Kitada, Masahiro| Takahashi, Masato| Kato, Hiroaki| Kikawa, Yuichiro| Sakata, Eiko| Naito, Yoichi| Hasegawa, Yoshie| Saito, Tsuyoshi| Iwasa, Tsutomu| Takashima, Tsutomu| Aihara, Tomohiko| Mukai, Hirofumi| Hara, Fumikata| Shien, Tadahiko| Doihara, Hiroyoshi| Toyooka, Shinichi|
抄録 Chemotherapy-induced peripheral neuropathy (CIPN) is an important clinical challenge that threatens patients’ quality of life. This sub-study of the ABROAD trial investigated the influence of single nucleotide polymorphisms (SNPs) on CIPN, using genotype data from a randomized study to determine the optimal dose of a 3-week-cycle regimen of nab-paclitaxel (q3w nab-PTX) in patients with metastatic breast cancer (MBC). Patients with HER2-negative MBC were randomly assigned to three doses of q3w nab-PTX (SD: 260 mg/m2 vs. MD: 220 mg/m2 vs. LD: 180 mg/m2). Five SNPs (EPHA4-rs17348202, EPHA5-rs7349683, EPHA6-rs301927, LIMK2-rs5749248, and XKR4-rs4737264) were analyzed based on the results of a previous genome-wide association study. Per-allele SNP associations were assessed by a Cox regression to model the cumulative dose of nab-PTX up to the onset of severe or worsening sensory neuropathy. A total of 141 patients were enrolled in the parent study; 91(65%) were included in this sub-study. Worsening of CIPN was significantly greater in the cases with XKR4 AC compared to those with a homozygote AA (HR 1.86, 95%CI: 1.00001−3.46, p=0.049). There was no significant correlation of CIPN with any other SNP. A multivariate analysis showed that the cumulative dose of nab-PTX was most strongly correlated with CIPN (p<0.01).
キーワード metastatic breast cancer taxane-induced peripheral neuropathy chemotherapy-induced peripheral neuropathy nab-paclitaxel single nucleotide polymorphism
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 661
終了ページ 671
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549768
Web of Science KeyUT 000905195100006
JaLCDOI 10.18926/AMO/64115
フルテキストURL 76_6_651.pdf
著者 Bright Osman Abugri| Matsusaki, Takashi| Ren, Wanxu| Morimatsu, Hiroshi|
抄録 Maintaining perioperative normothermia decreases the post-surgery surgical site infection (SSI) rate. We investigated whether SSI is associated with intraoperative hypothermia in total hip (THA) and total knee (TKA) arthroplasties by retrospectively analyzing 297 THA and TKA cases. The patients’ intraoperative core body temperature (BT) was measured by bladder catheter or forehead sensor. We evaluated the associations between SSI and intraoperative BT and other variables and patient characteristics. Fifty-six patients (18.8%) had hypothermia (BT <36°C); 43 developed SSI (14.5%); only five had hypothermia (11.6%). Intraoperative hypothermia and SSI were not significantly associated. The SSI group had more men (34.9% vs. 18.1%) and THA patients (77.4%), a longer mean surgical duration (174.3 vs. 143.5 mins), and a higher average BT (36.4°C vs. 36.2°C) than the no-SSI group. The SSI patients had a higher intraoperative BT. A multivariable analysis revealed that SSI was associated with male sex (OR 2.3, 95%CI: 1.031-4.921, p=0.042), longer surgery (OR, 1.01, 95%CI: 1.003-1.017, p=0.004), THA (OR 3.6, 95%CI: 1.258-10.085, p=0.017), and intraoperative BT >36.0°C (OR 3.6, 95%CI: 1.367-9.475, p=0.009). Intraoperative hypothermia was not associated with SSI in adults who underwent THA or TKA. These results suggest that hypothermia might not be the problem for SSI.
キーワード hypothermia surgical site infection total hip arthroplasty (THA) knee arthroplasty (TKA)
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 651
終了ページ 660
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549767
Web of Science KeyUT 000905195100005
JaLCDOI 10.18926/AMO/64112
フルテキストURL 76_6_625.pdf
著者 Liu Zhisheng| Li, Qingmei| Wang, Ye| Ge, Yunjie|
抄録 This investigation aimed to uncover the impact of a long noncoding RNA, SET-binding factor 2 antisense RNA1 (SBF2-AS1) on the malignant progression of gastric cancer (GC) and to further explore its underlying mechanism. SBF2-AS1 expression was quantified by qRT-PCR in GC cell lines and GC tissues. In vitro loss-of-function studies of SBF2-AS1, accompanied by flow cytometry, CCK-8, and cell invasion tests, were applied to elucidate the impact of SBF2-AS1 on the tumor progression of GC cells. Finally, Western blotting and a luciferase assay were used to detect WNT/LRP5 signaling pathway activation. SBF2-AS1 was aberrantly expressed in GC cell lines (p<0.05) and GC tissues (p<0.05). Cell invasive and proliferative capabilities were inhibited via SBF2-AS1 knockdown, resulting in apoptosis of NCI-N87 and MKN74 cells. Additionally, online database analysis uncovered a positive correlation between SBF2-AS1 and the Wnt/LRP5 signaling pathway (p<0.05). SBF2-AS1 knockdown blocked the Wnt/LRP5 signaling pathway, whereas the effects of SBF2-AS1 knockdown on the malignant genotype of MKN74 as well as NCI-N87 cells were partially restored by triggering the Wnt/ LRP5 signaling pathway. High expression of SBF2-AS1 was found in GC, the malignant progression of which was repressed via SBF2-AS1 knockdown by inhibiting the Wnt/LRP5 signaling pathway.
キーワード gastric cancer (GC) SET-binding factor 2 antisense RNA1 (SBF2-AS1) invasion proliferation signaling
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
巻 76巻
号 6号
出版者 Okayama University Medical School
開始ページ 625
終了ページ 633
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549764
Web of Science KeyUT 000905195100002
JaLCDOI 10.18926/AMO/64033
フルテキストURL 76_5_527.pdf
著者 Makihara, Seiichiro| Kariya, Shin| Miyamoto, Shotaro| Uraguchi, Kensuke| Oka, Aiko| Tsumura, Munechika| Noda, Yohei| Ando, Mizuo| Okano, Mitsuhiro|
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-10
巻 76巻
号 5号
出版者 Okayama University Medical School
開始ページ 527
終了ページ 533
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352799
Web of Science KeyUT 000884907100005
JaLCDOI 10.18926/AMO/64024
フルテキストURL 76_5_489.pdf
著者 Matsumoto, Yuji| Ichikawa, Tomotsugu| Kurozumi, Kazuhiko| Date, Isao|
抄録 Glioblastoma (GBM) is a fatal primary malignant brain tumor in adults. Despite decades of research, the prognosis for GBM patients is still disappointing. One major reason for the intense therapeutic resistance of GBM is inter- and intra-tumor heterogeneity. GBM-intrinsic transcriptional profiling has suggested the presence of at least three subtypes of GBM: the proneural, classic, and mesenchymal subtypes. The mesenchymal subtype is the most aggressive, and patients with the mesenchymal subtype of primary and recurrent tumors tend to have a worse prognosis compared with patients with the other subtypes. Furthermore, GBM can shift from other subtypes to the mesenchymal subtype over the course of disease progression or recurrence. This phenotypic transition is driven by diverse tumor-intrinsic molecular mechanisms or microenvironmental factors. Thus, better understanding of the plastic nature of mesenchymal transition in GBM is pivotal to developing new therapeutic strategies. In this review, we provide a comprehensive overview of the current understanding of the elements involved in the mesenchymal transition of GBM and discuss future perspectives.
キーワード glioma glioblastoma mesenchymal subtype mesenchymal transition heterogeneity
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2022-10
巻 76巻
号 5号
出版者 Okayama University Medical School
開始ページ 489
終了ページ 502
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352795
Web of Science KeyUT 000884907100001
フルテキストURL fulltext.pdf
著者 Tsuji, Hironori| Tetsunaga, Tomoko| Tetsunaga, Tomonori| Misawa, Haruo| Oda, Yoshiaki| Takao, Shinichiro| Nishida, Keiichiro| Ozaki, Toshifumi|
キーワード caregiver burden chronic pain fear-avoidance model self-efficacy Zarit Burden Interview
発行日 2022-09-30
出版物タイトル Medicine
巻 101巻
号 39号
出版者 Lippincott Williams & Wilkins
開始ページ e30802
ISSN 0025-7974
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 the Author(s).
論文のバージョン publisher
PubMed ID 36181114
DOI 10.1097/MD.0000000000030802
Web of Science KeyUT 000862039900121
関連URL isVersionOf https://doi.org/10.1097/MD.0000000000030802
フルテキストURL fulltext.pdf
著者 Takahara, Masahiro| Hiraoka, Sakiko| Ohmori, Masayasu| Takeuchi, Keiko| Takei, Kensuke| Yasutomi, Eriko| Igawa, Shoko| Yamamoto, Shumpei| Yamasaki, Yasushi| Inokuchi, Toshihiro| Kinugasa, Hideaki| Harada, Keita| Ohnishi, Hideki| Okada, Hiroyuki|
キーワード bowel wall thickness Mayo endoscopic subscore classification transabdominal ultrasonography ulcerative colitis
発行日 2022-09-15
出版物タイトル Internal Medicine
巻 61巻
号 18号
出版者 The Japanese Society of Internal Medicine
開始ページ 2703
終了ページ 2709
ISSN 0918-2918
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 The Japanese Society of Internal Medicine
論文のバージョン publisher
PubMed ID 35185047
DOI 10.2169/internalmedicine.8827-21
Web of Science KeyUT 000857218300001
関連URL isVersionOf https://doi.org/10.2169/internalmedicine.8827-21
フルテキストURL fulltext.pdf
著者 Iwamuro, Masaya| Takahashi, Takahide| Watanabe, Natsuki| Abe, Makoto| Sakae, Hiroyuki| Kono, Yoshiyasu| Kanzaki, Hiromitsu| Tanaka, Takehiro| Kawano, Seiji| Otsuka, Fumio| Kawahara, Yoshiro| Yanai, Hiroyuki| Okada, Hiroyuki|
キーワード eradication flow cytometry Helicobacter pylori T lymphocytes
発行日 2022-08-26
出版物タイトル Medicine
巻 101巻
号 34号
出版者 Lippincott Williams & Wilkins
開始ページ e30241
ISSN 0025-7974
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 the Author(s).
論文のバージョン publisher
PubMed ID 36042652
DOI 10.1097/MD.0000000000030241
Web of Science KeyUT 000847532100050
関連URL isVersionOf https://doi.org/10.1097/MD.0000000000030241
フルテキストURL fulltext.pdf
著者 Matsuoka-Uchiyama, Natsumi| Tsuji, Kenji| Sang, Yizhen| Takahashi, Kensaku| Fukushima, Kazuhiko| Takeuchi, Hidemi| Inagaki, Kenichi| Uchida, Haruhito A.| Kitamura, Shinji| Sugiyama, Hitoshi| Wada, Jun|
発行日 2022-09-02
出版物タイトル Scientific Reports
巻 12巻
号 1号
出版者 Nature Portfolio
開始ページ 14999
ISSN 2045-2322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2022
論文のバージョン publisher
PubMed ID 36056164
DOI 10.1038/s41598-022-19226-0
Web of Science KeyUT 000849436000046
関連URL isVersionOf https://doi.org/10.1038/s41598-022-19226-0
JaLCDOI 10.18926/AMO/63904
フルテキストURL 76_4_447.pdf
著者 Umemura, Hiroshi| Fukuda, Yoshiaki| Miyashita, Tetsuo| Nakayama, Tomohiro|
抄録 The erythrocyte sedimentation rate (ESR) is a widely used marker of inflammation, but the detailed mechanisms underlying the ESR remain unclear. We retrospectively collected laboratory data from our hospital’s laboratory information system, and performed multiple linear regression analysis and correlation analysis to determine relationships between the ESR and other laboratory test parameters. The alpha-2, beta-2, and gamma fractions from serum protein electrophoresis, serum immunoglobulin (Ig) G, IgA, IgM, and complement C3 levels, plasma fibrinogen levels, and platelet count showed positive effects on the ESR; however, the serum albumin level showed negative effects. Since erythrocytes are negatively charged, an increase in positively charged proteins and a decrease in negatively charged albumin were suggested to increase the ESR. Notably, C-reactive protein (CRP) showed the third-strongest correlation with the ESR despite having no significant effect on the ESR. We also reviewed cases with discordant ESR and CRP levels to compare the disease profiles of high ESR/low CRP patients and low ESR/high CRP patients. The patients with high ESR/low CRP had a completely different disease profile from those with low ESR/high CRP. Since the ESR and CRP have different roles, they should be used as markers in a context-dependent manner.
キーワード complement erythrocyte sedimentation rate fibrinogen immunoglobulin serum protein electrophoresis
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-08
巻 76巻
号 4号
出版者 Okayama University Medical School
開始ページ 447
終了ページ 455
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36123160
JaLCDOI 10.18926/AMO/63895
フルテキストURL 76_4_409.pdf
著者 Higashikawa, Toshihiro| Shigemoto, Kenji| Goshima, Kenichi| Iwai, Shintarou| Moriyama, Manabu| Usuda, Daisuke| Hangyou, Masahiro| Inujima, Hiromi| Nozaki, Kakeru| Yamaguchi, Miyako| Usuda, Kimiko| Nakahashi, Takeshi| Matsumoto, Tadami| Takashima, Shigeki| Kanda, Tsugiyasu| Horii, Takeshi| Okuro, Masashi| Sawaguchi, Takeshi|
抄録 We assessed risk factors for postoperative urinary retention (UR) in elderly males with femoral bone fractures: 169 Japanese males (mean age 81.95 ± 1.19 years) who had undergone hip surgery at a municipal hospital (Toyama, Japan). A multiple logistic regression analysis was used to test possible risk factors for UR: age, body mass index, serum albumin, cognitive impairment, activities of daily living (ADL), and history of diabetes mellitus (DM). UR occurred in 24 (14.2%) of the 169 patients. A multivariate logistic regression analysis with age adjustment showed that ADL (odds ratio [OR] 3.88; 95% confidence interval [CI]: 1.2-12.5, p=0.023) was significantly associated with the development of UR, and a history of DM showed marginal significance for UR occurrence (OR 0.36, 95%CI: 0.11-10, p=0.064). These results suggests that ADL is a risk factor for UR development in elderly males who have undergone surgery for femoral neck or trochanter fractures.
キーワード elderly femoral bone fracture albumin urinary retention activities of daily living
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-08
巻 76巻
号 4号
出版者 Okayama University Medical School
開始ページ 409
終了ページ 414
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36123155
Web of Science KeyUT 000882167300006
JaLCDOI 10.18926/AMO/63894
フルテキストURL 76_4_399.pdf
著者 Kajiwara, Yukiko| Iwamoto, Takayuki| Zhu, Yidan| Kochi, Mariko| Shien, Tadahiko| Taira, Naruto| Doihara, Hiroyoshi| Toyooka, Shinichi|
抄録 According to a recent report, a low Ki67 level after short-term preoperative hormone therapy (post-Ki67) might suggest a more favorable prognosis compared with a high post-Ki67 level in patients with hormone receptorpositive/human epidermal growth factor 2-negative (HR+/HER2−) breast cancer with high levels of Ki67. This study aimed to evaluate the pre-treatment genetic differences between these two patient groups. Forty-five luminal B-like patients were stratified into two groups, namely, a group with high (H→H) and one with low (H→L) Ki67 levels after short-term preoperative aromatase inhibitor (AI) treatment. We compared pre-treatmentgene expression profiles between the two groups. In gene level analysis, there was no significant difference between the two groups by the class comparison test. In pathway analysis, five metabolism-related gene sets were significantly upregulated in the H→L group (p≤0.05). In the search for novel targets, five genes (PARP, BRCA2, FLT4, CDK6, and PDCD1LG2) showed significantly higher expression in the H→H group (p≤0.05). Several metabolism-related pathways were associated with sensitivity to AI. In the future, it will be necessary to seek out new therapeutic strategies for the poor prognostic group with high post-Ki67.
キーワード breast cancer short-term hormone therapy gene expression profiling Ki-67 targeted therapy
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-08
巻 76巻
号 4号
出版者 Okayama University Medical School
開始ページ 399
終了ページ 408
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36123154
Web of Science KeyUT 000882167300005